Journal of Alzheimers Disease

Article	Citations
Needs of people living with young-onset dementia and family carers, explored by dementia subtype, phase in the disease process, and living setting: A scoping review	190
Early CA2 Tau Inclusions Do Not Distinguish an Age-Related Tauopathy from Early Alzheimer’s Disease	157
Japan-multimodal intervention trial for the prevention of dementia in older people with lifestyle-related diseases: A community-based, 18-month, randomized controlled trial	132
Individual electric field in cortical white matter is correlated with cognitive improvement in patients with mild cognitive impairment due to Alzheimer's disease after repetitive transcranial magnetic	127
p53 SUMOylation promotes neurogenesis defects in APP/PS1 mice	105
Peripheral blood immune cell phenotypes and Alzheimer’s disease: A mediation Mendelian randomization study	101
Hydrate to keep the amyloid away	88
From autopsy to PET to cerebrospinal fluid to blood: Quantifying reference-standard dependence in Alzheimer's disease amyloid biomarker validation	85
Sex-specific accelerated epigenetic aging in the Alzheimer's disease spectrum	83
Altered temporal dynamics of intrinsic brain activity in mild cognitive impairment with olfactory dysfunction	71
IL-34/TREM2 modulates microglia-mediated inflammation and provides neuroprotection in a mouse model of sporadic Alzheimer's disease	68
The Predictive Ability of Blood Neurofilament Light Chain in Predicting Cognitive Decline in the Alzheimer’s Disease Continuum: A Systematic Review and Meta-Analysis	66
Under-Diagnosis of Dementia with Lewy Bodies in Individuals Racialized as Black: Hypotheses Regarding Potential Contributors	65
HARMONISATION – A multimodal prospective study of vascular cognitive impairment in multi-ethnic Asians: Cohort profile, progress, current contributions, and future impact	62
Dementia in Denmark: Uncovering the causes of death and life years lost in a nationwide, register-based cohort study	62
Neurophysiological Alterations of the Visual Pathway in Posterior Cortical Atrophy: Systematic Review and a Case Series	60
Comparison of visit-to-visit blood pressure variability and time in target range in predicting risk for cognitive outcomes in the SPRINT trial	60
The association between dual sensory impairment and dementia: A systematic review and meta-analysis	60
One of the binding proteins for administered amyloid-β appears to be anti-Aβ IgG antibody in amyloid plaques	60
Unraveling the impact of risk factors on the ferroptosis-Alzheimer's disease link for early detection	59
Soda consumption and risk of dementia: The Northern Manhattan study	54
Diagnostic accuracy of Alzheimer's Questionnaire in identifying dementia among Filipinos in a tertiary hospital	53
Vaccines and Dementia: Part II. Efficacy of BCG and Other Vaccines Against Dementia	52
FTIR Spectroscopy and Blood-Derived Extracellular Vesicles Duo in Alzheimer’s Disease	50
Mediation effect of neuropsychological factors on the relationship between social networks and mild cognitive impairment in older adults	50

Corrigendum to “Leucettinib-21, a DYRK1A Kinase Inhibitor as Clinical Drug Candidate for Alzheimer's Disease and Down Syndrome”	49
Novel predictors of Alzheimer's disease in Down syndrome identified using machine learning	49
Blood pressure dynamic instability and neurodegeneration in older adults	48
Multimorbidity, Social Engagement, and Age-Related Cognitive Decline in Older Adults from the Rancho Bernardo Study of Healthy Aging	46
Regional gyrification alterations and metabolic correlates in biologically defined Alzheimer's disease using a multimodal approach	46
Cerebrospinal fluid acetylcholine is not a reliable diagnostic marker for Alzheimer's disease and dementia with Lewy bodies	46
Patterns of cortical atrophy are associated with specific cognitive domains in patients with logopenic primary progressive aphasia	45
Uncovering pathology, subjective cognitive complaints, and sex in early Alzheimer's disease	44
Discovering potential ERK1 inhibitors from natural products for therapeutic targeting of Alzheimer's disease	44
Relationship periodontitis and Alzheimer's disease: Relevant aspects from an epigenetic view	43
Neural Computation-Based Methods for the Early Diagnosis and Prognosis of Alzheimer’s Disease Not Using Neuroimaging Biomarkers: A Systematic Review	43
Exploring the potential of acupuncture as a complementary treatment for Alzheimer's disease: Pushing the boundaries forward	42
Sex-Related Differences in the Association Between Body Mass Index and Dementia Risk	40
Reduction in Constitutively Activated Auditory Brainstem Microglia in Aging and Alzheimer’s Disease	40
Putting the Brakes on Accelerated Cognitive Decline in Alzheimer’s Disease with Epileptic Activity	40
Late Midlife Subclinical Infarct Burden and Risk of Dementia: The Atherosclerosis Risk in Communities Neurocognitive Study	40
Vitamin D, a Secosteroid Hormone and Its Multifunctional Receptor, Vitamin D Receptor, in Alzheimer’s Type Neurodegeneration	40
Assessing Longitudinal Cognitive Change in Mild Cognitive Impairment Using Estimated Standardized Regression-Based Formulas	40
Gene Association Study of the Urokinase Plasminogen Activator and Its Receptor Gene in Alzheimer’s Disease	40
Association of Anemia with Cognitive Function and Dementia Among Older Adults: The Role of Inflammation	39
Effects of Exercise on Urinary AD7c-NTP (Alzheimer-Associated Neuronal Thread Protein) Levels and Cognitive Function Among Active Korean Elderly: A Randomized Controlled Trial	39
Common Molecular Signatures Between Coronavirus Infection and Alzheimer’s Disease Reveal Targets for Drug Development	37
Incident Dementia After Spontaneous Intracerebral Hemorrhage	37
Slovenian Memory Clinic Organization with the Introduction of Potential New Alzheimer’s Disease Treatment	36
Understanding of Dementia in the Polish Language: A Frame Semantic Approach	35
Alzheimer’s Disease Pathology Outside of the Cerebrum Is Related to a Higher Odds of Dementia	35
Search in the Periphery for Potential Inflammatory Biomarkers of Dementia with Lewy Bodies and Alzheimer’s Disease	35
Subjective Cognitive Decline Is Associated with Health-Related Quality of Life in the Middle-Aged to Elderly Population	35
Attentional Control in Subjective Cognitive Decline	35
Decreased Hemodynamic Responses in Left Parietal Lobule and Left Inferior Parietal Lobule in Older Adults with Mild Cognitive Impairment: A Near-Infrared Spectroscopy Study	34
Fatty Acid-Binding Protein 3 Is a Marker of Neurodegeneration and White Matter Hyperintensity Burden in Mexican American Older Adults	34
Cognitive Impairment and Associated Factors Among Adults with Type 2 Diabetes Mellitus in Bahir Dar City Referral Hospitals, 2021: Cross-Sectional Study	34
Hypertensive Aspects of Cardiometabolic Disorders Are Associated with Lower Brain Microstructure, Perfusion, and Cognition	34
Associations of the Harvard Automated Phone Task and Alzheimer’s Disease Pathology in Cognitively Normal Older Adults: Preliminary Findings	34
The CERAD Word List Memory Test: Normative Data Based on a Norwegian Population-Based Sample of Healthy Older Adults 70 Years and Above. The HUNT Study	34
Auditory Event-Related Potentials in Older Adults with Subjective Memory Complaints	33
Serum Uric Acid Levels in Neurodegenerative Disorders: A Cross-Sectional Study	33
Case Identification and Characterization of Migrants with Dementia in the Lazio Region Using Health Administrative Data	33
Associations Between Midlife Menopausal Hormone Therapy Use, Incident Diabetes, and Late Life Memory in the Wisconsin Longitudinal Study	33
Taxifolin for Cognitive Preservation in Patients with Mild Cognitive Impairment or Mild Dementia	33
Fall Risk, Sleep Behavior, and Sleep-Related Movement Disorders in Young Urbanites Exposed to Air Pollution	32
Mortality Risks and Causes of Death by Dementia Types in a Japanese Cohort with Dementia: NCGG-STORIES	32
Decoding the key mechanisms of ferroptosis and inflammation: Emerging therapeutic targets for Alzheimer's disease	32
Effects of Melissa officinalis Extract Containing Rosmarinic Acid on Cognition in Older Adults Without Dementia: A Randomized Controlled Trial	32
Efficacy of Souvenaid® Combined with Acetylcholinesterase Inhibitors in the Treatment of Mild Alzheimer’s Disease	32
Improved Prediction of Amyloid-β and Tau Burden Using Hippocampal Surface Multivariate Morphometry Statistics and Sparse Coding	32
Joint Computational/Cell-Based Approach for Screening Inhibitors of Tau Oligomerization: A Proof-of-Concept Study	32
Difficulties with Activities of Daily Living and Receipt of Care Among Older Adults with Cognitive Impairment: Differences Between Those Living Alone and Those Living with Others	32
Choroid plexus–glymphatic axis disruption in Alzheimer's disease: Cerebrospinal fluid expansion as a mediator of metabolic dysfunction and cognitive decline	32
Impacts of adapted dance on mood and physical function among persons living with Alzheimer's disease	31

Targeting GluR3 in Depression and Alzheimer’s Disease: Novel Compounds and Therapeutic Prospects	31
In-silico Codon Context and Synonymous Usage Analysis of Genes for Molecular Mechanisms Inducing Autophagy and Apoptosis with Reference to Neurodegenerative Disorders	30
Uncovering the Oxidative Stress Mechanisms and Targets in Alzheimer’s Disease by Integrating Phenotypic Screening Data and Polypharmacology Networks	30
Chain Mediation Analysis of the Effects of Nutrition and Cognition on the Association of Apolipoprotein E ɛ4 with Neuropsychiatric Symptoms in Alzheimer’s Disease	30
Multi-Site Cross-Site Inter-Rater and Test-Retest Reliability and Construct Validity of the MarkVCID White Matter Hyperintensity Growth and Regression Protocol	30
Spatial differences in gene expression across the dorsal raphe nucleus in a model of early Alzheimer's disease	30
Education attainment and nutritional status in the prevention of cognitive impairment in the hospitalized Chinese elderly	29
Association Between Carotid Plaque and Alzheimer’s Disease Cerebrospinal Fluid Biomarkers and Cognitive Function in Cognitively Intact Adults: The CABLE Study	29
Relationship Between Endothelial Function, Vital Parameters, and Cognitive Performance in Community Dwellers with Subjective Cognitive Decline: An Observational Study with Six Months Follow Up	29
A multi-modal and multi-stage region of interest-based fusion network convolutional neural network model to differentiate progressive mild cognitive impairment from stable mild cognitive impairment	29
CMS121, a Novel Drug Candidate for the Treatment of Alzheimer’s Disease and Age-Related Dementia	29
Correlation Between Amyloid PET Imaging and Discordant Cerebrospinal Fluid Biomarkers Results in Patients with Suspected Alzheimer’s Disease	29
Neurovascular Correlates of Cobalamin, Folate, and Homocysteine in Dementia	29
Designing Newer Omega-3 Supplementation Trials for Cognitive Outcomes: A Systematic Review Guided Analysis	29
Remnant cholesterol and cognitive function: Evidence from the China health and retirement longitudinal study	29
Characterization of Early Alzheimer’s Disease-Like Pathological Alterations in Non-Human Primates with Aging: A Pilot Study	28
Assessment of the Causal Effect of IgG N-Glycosylation Level on Risk of Dementia: A 2-Sample Mendelian Randomization Study	28
Sexual dimorphism, altered hippocampal glutamatergic neurotransmission, and cognitive impairment in APP knock-in mice	28
Learning From Mistakes: Cognitive and Metabolic Correlates of Errors on Picture Naming in the Alzheimer’s Disease Spectrum	28
Low Serum Insulin-like Growth Factor-I Is Associated with Decline in Hippocampal Volume in Stable Mild Cognitive Impairment but not in Alzheimer’s Disease	28
Experimental Periodontitis Deteriorates Cognitive Function and Impairs Insulin Signaling in a Streptozotocin-Induced Alzheimer’s Disease Rat Model	28
Postmortem tau in the CA2 region of the hippocampus in older adult men who participated in youth amateur American-style football	28
Physical Activity in Mild Vascular Cognitive Impairment: Results of the AFIVASC Randomized Controlled Trial at 6 Months	28
Alzheimer’s Disease with Epileptiform EEG Activity: Abnormal Cortical Sources of Resting State Delta Rhythms in Patients with Amnesic Mild Cognitive Impairment	28
Autoantibodies in Alzheimer's disease: Multifaceted roles and therapeutic horizons	28
Sleep disturbances and language function impairment in the elderly: Evidence of limbic and prefrontal tracts involvement	28
Multicomponent exercise interventions for older adults with Alzheimer's disease: A systematic review and meta-analytical perspective	27
Prescription-based association of P-glycoprotein substrates with Alzheimer's disease risk: A nested case-control study	27
The association between hemoglobin level and risk of developing dementia	27
Impact of Cognitive Demand on Eye Movement Pattern in Patients with Alzheimer’s Disease	26
Physical Activity Self-Report Is Not Reliable Among Subjects with Mild Vascular Cognitive Impairment: The AFIVASC Study	26
Cerebral Small Vessel Disease Burden Predicts Neurodegeneration and Clinical Progression in Prodromal Alzheimer’s Disease	26
Disruptions of deep medullary veins and MRI indices of glymphatic function in cerebral small vessel disease	26
Effects of Sideritis scardica Extract on Scopolamine-Induced Learning and Memory Impairment in Mice	26
Impact of Chronic Conditions and Dementia in Rural West Texas: A Healthy Aging Study	26
Helicobacter pylori and Alzheimer's disease risk: The HUNT study	25
Depression and Agitation Factors Are Related to Regional Brain Atrophy and Faster Longitudinal Cognitive Decline in Mild Cognitive Impairment	25
Timing of neurorehabilitation and subsequent Alzheimer's disease risk in patients with moderate to severe traumatic brain injury: A nationwide retrospective cohort study in the United States	25
COVID-19 and Alzheimer’s Disease: What Is the Connection?	25
Lucidity in deeply forgetful people: A national U.S. survey of caregivers’ reactions	25
GAPDH citrullination as a molecular signature of neurodegeneration, assessed in prion diseases	25
Alzheimer’s Disease Is a Multi-Organ Disorder: It May Already Be Preventable	25
Brain 11β-Hydroxysteroid Dehydrogenase Type 1 Occupancy by Xanamem™ Assessed by PET in Alzheimer’s Disease and Cognitively Normal Individuals	25
The role of carotenoids from red mamey fruit ( Pouteria sapota ) against amyloid-β monomers in Alzheimer's disease: Computational analysis and ADMET pred	25
Meaning in life and neurobiomarkers of brain health in the UK Biobank	25
Associations Between TREML2 Gene Variants and Alzheimer’s Disease: Biomarkers, Neuroimage, and Cognition	24
Neural flexibility is higher in Alzheimer's disease and predicts Alzheimer's disease transition	24
A systematic review of lifestyle-based interventions for managing Alzheimer's disease: Insights from randomized controlled trials	24
Neutrophil percentage-to-albumin ratio is associated with cognitive function in adults aged over 60 years: An analysis of data from the NHANES 2011–2014	24
Hearing loss, plasma neurodegenerative biomarkers, and cognitive function: Independent and additive effects	24
Identification and cognitive function prediction of Alzheimer's disease based on multivariate pattern analysis of hippocampal volumes	24
Reporting of comorbidities and health status of participants in clinical trials testing amyloid- and tau-targeting monoclonal antibodies for Alzheimer's disease: A systematic review	24
Predictors of MRI-estimated brain iron deposition in dementia and Parkinson's disease-associated subcortical regions: Genetic and observational analysis in UK Biobank	24
Cyrus A. Raji, MD, PhD, is the recipient of the 2025 Mark A. Smith Alzheimer Award	23
Treating Alzheimer’s Disease: Focusing on Neurodegenerative Consequences	23
Effects of Intermittent Hypoxia Protocols on Cognitive Performance and Brain Health in Older Adults Across Cognitive States: A Systematic Literature Review	23
Baseline Frontoparietal Gray Matter Volume Predicts Executive Function Performance in Aging and Mild Cognitive Impairment at 24-Month Follow-Up	23
Classifying Alzheimer’s Disease Neuropathology Using Clinical and MRI Measurements	23
Characterizing structure-function coupling in subjective memory complaints of preclinical Alzheimer's disease	23
What Impact Does the Diagnosis of Mild Cognitive Impairment Have on the Wellbeing, Everyday Behavior, and Healthcare Utilization of People and Their Carers? A Systematic Review	23
Exploring the Genetic Heterogeneity of Alzheimer’s Disease: Evidence for Genetic Subtypes	23
Associations of Physical Activity Engagement with Cerebral Amyloid-β and Tau from Midlife	23
Association Between Statin Use and Dementia, and Related Mechanisms: A Bibliometric Analysis from 2007 to 2023	23
Validation of the Updated “LIfestyle for BRAin health” (LIBRA) Index in the English Longitudinal Study of Ageing and Maastricht Aging Study	23
The Impact of Misaligned Perceived and Objective Fall Risk in Cognitively Impaired Older People	23
go4cognition: Combined Physiological and Cognitive Intervention in Mild Cognitive Impairment	23
The Role of Interferon- α in Neurodegenerative Diseases: A Systematic Review	22
Is Carer Management Style Associated with Longitudinal Functional Decline in Dementia?	22
Code-Based Algorithms for Identifying Dementia in Electronic Health Records: Bridging the Gap Between Theory and Practice	22
Improving Regression Analysis with Imputation in a Longitudinal Study of Alzheimer’s Disease	22
Posttraumatic Stress and Traumatic Brain Injury: Cognition, Behavior, and Neuroimaging Markers in Vietnam Veterans	22
Multifactorial Causation of Alzheimer’s Disease Due to COVID-19	22
Relationship Between Non-Cognitive Intrinsic Capacity and Activities of Daily Living According to Alzheimer’s Disease Stage	22
Non-Modifiable Factors as Moderators of the Relationship Between Physical Activity and Brain Volume: A Cross-Sectional UK Biobank Study	22
Effect and Mechanism of Rapamycin on Cognitive Deficits in Animal Models of Alzheimer’s Disease: A Systematic Review and Meta-analysis of Preclinical Studies	22
Effects of Type 2 Diabetes on the Neuropsychological Profile in Mild Cognitive Impairment	22
Neural Stem Cells in the Treatment of Alzheimer’s Disease: Current Status, Challenges, and Future Prospects	22
Clinical Quality Indicators for Monitoring Hospitalizations Among Older People with Dementia Accessing Aged Care Services	22
Dynamic PET imaging in patients with unilateral carotid occlusion shows lateralized cerebral hypoperfusion, but no amyloid binding	22
Association of Basal Forebrain Volume with Amyloid, Tau, and Cognition in Alzheimer’s Disease	22

Prevalence and Factors Associated with Subjective Memory Complaint in a Semi-Rural Community in Chile	22
Getting Insight to the Lived Emotional Experience of People with Alzheimer’s Disease Shortly After Diagnosis: A Phenomenological Approach	22
Gait and movement analysis for discrimination between people with dementia and healthy control persons based on pose estimation and machine learning	21
Acute cerebral blood flow response to heavy cream ingestion in older adults: A non-randomized pilot study	21
Distinct patterns of microstructural brain changes in Alzheimer's disease subtypes: Diffusion MRI metrics in braak stage-related regions	21
Sex Modifies the Associations of APOE ɛ4 with Neuropsychiatric Symptom Burden in Both At-Risk and Clinical Cohorts of Alzheimer’s Disease	21
Landscape of Double-Stranded DNA Breaks in Postmortem Brains from Alzheimer’s Disease and Non-Demented Individuals	21
Boswellic Acids Improve Clinical Cognitive Scores and Reduce Systemic Inflammation in Patients with Mild to Moderate Alzheimer’s Disease	21
Antidepressant and anxiolytic medications and risk of mortality in people with dementia: A nested case-control study in Northern Ireland	21
Periodontitis associated with multi-region brain functional alterations and cognitive impairment: A cross-sectional study in normal cognition, amnestic mild cognitive impairment, and Alzheimer's disea	21
A nomogram including serum iron metabolism-related indicator and cerebral microbleeds for predicting vascular cognitive impairment in patients	21
Associations of Leisure Activities and Sleep Duration with Cognitive Function: A Nationwide Prospective Cohort Study of Chinese Old Adults	21
Lipopolysaccharides from Porphyromonas gingivalis indirectly induce neuronal GSK3β-dependent synaptic defects and cause cognitive decline in a low-amyloi	21
Posterior cortical atrophy in the age of anti-amyloid treatments: An 11-year retrospective study of eligible patients from the Leenaards Memory Center	21
Evaluation of early-phase 18 F-Florbetaben PET as a surrogate biomarker of neurodegeneration: In-depth comparison with 18	21
COVID-19 and neurodegeneration: Perspectives on the impact of viruses on the brain	21
Hyperglycemia Aggravates the Cerebral Ischemia Injury via Protein O-GlcNAcylation	21
The Brain Health Platform: Combining Resilience, Vulnerability, and Performance to Assess Brain Health and Risk of Alzheimer’s Disease and Related Disorders	21
Association of Kidney Function with Risk of Incident Dementia: A Prospective Cohort Study of 275,167 UK Biobank Participants	21
Mild Cognitive Impairment, Reversion Rates, and Associated Factors: Comparison of Two Diagnostic Approaches	20
Integrating kidney function assessment into the clinical interpretation of plasma Alzheimer's disease biomarkers	20
Perceived everyday discrimination and its effect on cognitive function through depression in diverse populations: A HABS-HD study	20
Associations of dietary protein and amino acid intakes with disability-adjusted life years for Alzheimer's disease in Japanese people	20
Mites, microbes, and neurodegeneration: A unified environmental hypothesis for Parkinson's disease, Alzheimer's disease, and Lewy body dementia	20
Shortening of Saccades as a Possible Easy-to-Use Biomarker to Detect Risk of Alzheimer’s Disease	20
Recent Advances in Drug Delivery Systems Targeting Insulin Signalling for the Treatment of Alzheimer’s Disease	20
Associations between neuropsychiatric symptoms and pathology in clinicopathologically defined Alzheimer's disease, Alzheimer's disease with Lewy bodies, and dementia with Lewy bodies	20
Distinct brain atrophy patterns in Lewy body disease: The impact and interaction of comorbid neuropathologies revealed by voxel-based morphometry	20
Real-world experience with baseline characteristics and safety of lecanemab for Alzheimer's disease in Eastern China	20
Evaluating MRI correlates of lifestyle-based dementia risk reduction: Results from the AgeWell.de imaging study	20
A Pilot Study of Near-Infrared Light Treatment for Alzheimer’s Disease	20
Phosphorylated peptide Tau-pT181 induced tau aggregation and cognitive dysfunction	20
Neuropsychiatric signs and symptoms clusters and regional amyloid on 18 F-FC119S PET in Alzheimer's disease	20
Impact of coronary interventions on dementia diagnosis by race: Insights from a multi-hospital heart-brain registry	20
Explore the Role of Frailty as a Contributor to the Association Between AT(N) Profiles and Cognition in Alzheimer’s Disease	19
Incretin Mimetics as Potential Disease Modifying Treatment for Alzheimer’s Disease	19
Citicoline: A Cholinergic Precursor with a Pivotal Role in Dementia and Alzheimer’s Disease	19
Characterization of Apathy-Like Behaviors in Mouse Models of Down Syndrome	19
Relevance of Subjective Cognitive Decline in Older Adults with a First-Degree Family History of Alzheimer’s Disease	19
Gamma Frequency Inhibits the Secretion and Aggregation of Amyloid-β and Decreases the Phosphorylation of mTOR and Tau Proteins in vitro	19
Potentially Inappropriate Medication Use in Community-Dwelling Older Adults Living with Dementia	19
Circulating Molecular Chaperones in Subjects with Amnestic Mild Cognitive Impairment and Alzheimer’s Disease: Data from the Zabùt Aging Project	19
Association of Plastic Exposure with Cognitive Function Among Chinese Older Adults	19
Digital Biomarkers for the Assessment of Non-Cognitive Symptoms in Patients with Dementia with Lewy Bodies: A Systematic Review	19
Amyloid-Negative, Neurodegeneration-Negative Amnestic Mild Cognitive Impairment	19
Diffusion Imaging of Gray Matter Microstructure in Alzheimer’s Disease	19
Projecting the Likely Impact of COVID-19 Infections on the Prevalence of Dementia in the United States	19
A Machine Learning Approach for Early Diagnosis of Cognitive Impairment Using Population-Based Data	19
CERAD (Consortium to Establish a Registry for Alzheimer’s Disease) Neuropsychology Assessment Battery: 35 Years and Counting	19
Influence of Subject-Specific Effects in Longitudinal Modelling of Cognitive Decline in Alzheimer’s Disease	19
Effects of Apolipoprotein E ɛ4 and Risk Factors on Domains of Cognition in Mild Cognitive Impairment and Dementia	19
Leucettinib-21, a DYRK1A Kinase Inhibitor as Clinical Drug Candidate for Alzheimer’s Disease and Down Syndrome	19
Identifying Comorbidity Patterns in People with and without Alzheimer’s Disease Using Latent Dirichlet Allocation	19
Societal Costs of Dementia: 204 Countries, 2000–2019	19
Sex Differences in Dementia, Cognition, and Health in the Cognitive Function and Ageing Studies (CFAS)	19
Prevalence and Safety of COVID-19 Vaccination in Community-Dwelling People with Dementia: Findings from a Tertiary Memory Clinic in Italy	19
The Dual Role of Astrocyte-Derived Exosomes and Their Contents in the Process of Alzheimer’s Disease	19
Development and Characterization of Mouse-Specific Anti-Tau Monoclonal Antibodies: Relevance for Analysis of Murine Tau in Cerebrospinal Fluid	19
Investigating Casual Associations Among Gut Microbiota, Metabolites, and Neurodegenerative Diseases: A Mendelian Randomization Study	19
Towards the development of a management protocol for subjective cognitive decline: Insights from a cross-sectional and longitudinal analysis of multimodal data from a memory clinic	18
Mutual effects of sleep duration and traits on the risk of dementia: A prospective study in the UK Biobank	18
Dementia Knowledge, Attitude toward Dementia, and Confidence in Dementia Care: Impact of a Dementia Training on German Nursing Students	18
Vaccines and Dementia: Part I. Non-Specific Immune Boosting with BCG: History, Ligands, and Receptors	18
Retraction to: Potential Mechanisms Linking Cholesterol to Alzheimer’s Disease-like Pathology in Rabbit Brain, Hippocampal Organotypic Slices, and Skeletal Muscle	18
Blood Tests for Alzheimer’s Disease: Increasing Efforts to Expand and Diversify Research Participation Is Critical for Widespread Validation and Acceptance	18
Testing a Polygenic Risk Score for Morphological Microglial Activation in Alzheimer’s Disease and Aging	18
PROTEIMERs as catalytic inhibitors of APP mRNA translation: Toward a new therapeutic for Alzheimer's disease	18
A Mini-Mental State Examination Formula May Help to Distinguish Alzheimer’s Disease from Dementia with Lewy Bodies	18
An Alzheimer’s Disease Mechanism Based on Early Pathology, Anatomy, Vascular-Induced Flow, and Migration of Maximum Flow Stress Energy Location with Increasing Vascular Disease	18
Repetitive transcranial magnetic stimulation enhances alpha power in Alzheimer's disease patients	18
Alzheimer-typical temporo-parietal atrophy and hypoperfusion are associated with a more significant cholinergic impairment in amnestic neurodegenerative syndromes	18
Hearing loss and the risk of dementia: A longitudinal analysis of the Korean National Health Insurance Service Senior Cohort	18
Including General Audiences in a Virtual Scientific Dementia Conference: Will They Get Anything From It?	18
Protocol for a Mixed-Methods Process Evaluation of BetterBrains: A Person-Centered Online Intervention to Delay Cognitive Decline in Adults at Risk of Dementia	18
Anti-CMV IgG Seropositivity is Associated with Plasma Biomarker Evidence of Amyloid-β Accumulation	18
The Association Between Cognition of Obstructive Sleep Apnea Patients and Urinary AD7c-NTP Level: Investigation and Application	18
Identification of Major Cognitive Disorders in Self-Reported versus Administrative Health Data: A Cohort Study in Quebec	18
Scavenging Reactive Oxygen Species Decreases Amyloid-β Levels via Activation of PI3K/Akt/GLUT1 Pathway in N2a/APP695swe Cells	18
Corrigendum to “The relationship between plasma oxidized low-density lipoprotein and all-cause cognitive impairment: A population-based cross-sectional study in a rural area of Xi’an, China”	18
Hippocampal transcriptome-wide association analysis of shared genetic risks between posttraumatic stress disorder and Alzheimer's disease	18
The relationship between plasma oxidized low-density lipoprotein and all-cause cognitive impairment: A population-based cross-sectional study in a rural area of Xi’an, China	18
Down syndrome and Alzheimer's disease: Oxidative stress in the neurodegenerative process	18
Do They Align? Congruence Between Patient Preferences of People Living with Cognitive Impairments and Physicians’ Judgements for Person-Centered Care: An Analytic Hierarchy Process Study	18
Biomarkers and Mindfulness: A Way Forward	18
Fear of Falling as a Behavioral Symptom in Neurocognitive Impaired Patients: Evidence from an Underrepresented Population	18
Exploring toxicity and mechanisms of DDTs in Alzheimer's disease through network toxicology and molecular docking insights	18
Patterns of Limitation in Physical Function in Late Midlife Associated with Late-Onset Alzheimer’s Disease and Related Dementias: A Cluster Analysis	18
Exploring the Association Between Opioid Use Disorder and Alzheimer’s Disease and Dementia Among a National Sample of the U.S. Population	17
A 14-Year Longitudinal Analysis of Healthcare Expenditure on Dementia and Related Factors (DEMENCOST Study)	17
Unveiling New Strategies Facilitating the Implementation of Artificial Intelligence in Neuroimaging for the Early Detection of Alzheimer’s Disease	17
Disrupted Excitation-Inhibition Balance in Cognitively Normal Individuals at Risk of Alzheimer’s Disease	17
Phonological and Semantic Fluency in Alzheimer’s Disease: A Systematic Review and Meta-Analysis	17
Pathological and Therapeutic Advances in Parkinson’s Disease: Mitochondria in the Interplay	17
TLR4/Rac1/NLRP3 Pathway Mediates Amyloid-β-Induced Neuroinflammation in Alzheimer’s Disease	17
Biomarkers and Risk Assessment of Alzheimer’s Disease in Low- and Middle-Income Countries	17